PA8527301A1 - 7-OXO-PYRIDOPIRIMIDINAS - Google Patents

7-OXO-PYRIDOPIRIMIDINAS

Info

Publication number
PA8527301A1
PA8527301A1 PA20018527301A PA8527301A PA8527301A1 PA 8527301 A1 PA8527301 A1 PA 8527301A1 PA 20018527301 A PA20018527301 A PA 20018527301A PA 8527301 A PA8527301 A PA 8527301A PA 8527301 A1 PA8527301 A1 PA 8527301A1
Authority
PA
Panama
Prior art keywords
disease
pyridopirimidinas
oxo
caused
syrdrome
Prior art date
Application number
PA20018527301A
Other languages
Spanish (es)
Inventor
Jian Jeffrey Chen
James Patrick Dunn
Julie Anne Lim
David Michael Goldstein
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PA8527301A1 publication Critical patent/PA8527301A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA: EN LA QUE R1, R2, R3 Y AR1 TIENEN LOS SIGNIFICADOS DEFINIDOS EN LA INVENCION, Y A METODOS DE OBTENCION Y A SU UTILIZACION PARA EL TRATAMIENTO DE TRASTORNOS CAUSADOS POR P38, P. EJ. EL METODO DE LA REIVINDICACION 26 O 27, EN EL QUE DICHO TRASTORNO CAUSADO POR P38 SE SELECCIONA ENTRE LA ARTRITIS, LA ENFERMEDAD DE CROHN, LA ENFERMEDAD DE ALZHEIMER, EL SINDROME DE INTESTINO IRRITABLE, EL SINDROME DE LA DEFICIENCIA RESPIRATORIA ADULTA Y LA ENFERMEDAD PUILMONAR OBSTRUCTIVA CRONICA.THE PRESENT INVENTION CONCERNS COMPOUNDS OF THE FORMULA: IN WHICH R1, R2, R3 AND AR1 HAVE THE MEANINGS DEFINED IN THE INVENTION, AND METHODS OF OBTAINING AND THEIR USE FOR THE TREATMENT OF CAUSES CAUSED BY P38, P. EX. THE METHOD OF THE REIVINDICATION 26 OR 27, IN WHICH SUCH DISORDER CAUSED BY P38 IS SELECTED BETWEEN ARTHRITIS, CROHN'S DISEASE, ALZHEIMER'S DISEASE, IRRITABLE INTESTINE SYNDROME, SYRDROME OF RESPIRATORY ADULMULARITY CHRONIC OBSTRUCTIVE.

PA20018527301A 2000-08-31 2001-08-28 7-OXO-PYRIDOPIRIMIDINAS PA8527301A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22958400P 2000-08-31 2000-08-31

Publications (1)

Publication Number Publication Date
PA8527301A1 true PA8527301A1 (en) 2002-07-30

Family

ID=22861859

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20018527301A PA8527301A1 (en) 2000-08-31 2001-08-28 7-OXO-PYRIDOPIRIMIDINAS

Country Status (15)

Country Link
EP (1) EP1315726A1 (en)
JP (1) JP4141830B2 (en)
KR (1) KR100571339B1 (en)
CN (1) CN1275964C (en)
AR (1) AR033681A1 (en)
AU (2) AU9378401A (en)
BR (1) BR0113628A (en)
CA (1) CA2420286A1 (en)
GT (1) GT200100191A (en)
MX (1) MXPA03001821A (en)
PA (1) PA8527301A1 (en)
PE (1) PE20020406A1 (en)
UY (1) UY26918A1 (en)
WO (1) WO2002018380A1 (en)
ZA (1) ZA200301079B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1315727B1 (en) * 2000-08-31 2005-06-29 F. Hoffmann-La Roche Ag 7-oxo pyridopyrimidines
US6518276B2 (en) 2000-08-31 2003-02-11 Syntex (U.S.A.) Llc 7-oxo-pyridopyrimidines (II)
BR0308937A (en) * 2002-04-03 2005-01-04 Hoffmann La Roche Fused imidazo compounds
DE60315826T2 (en) * 2002-04-19 2008-05-21 Smithkline Beecham Corp. NEW CONNECTIONS
US7084270B2 (en) 2002-08-14 2006-08-01 Hoffman-La Roche Inc. Pyrimido compounds having antiproliferative activity
UY27939A1 (en) 2002-08-21 2004-03-31 Glaxo Group Ltd COMPOUNDS
US7112676B2 (en) 2002-11-04 2006-09-26 Hoffmann-La Roche Inc. Pyrimido compounds having antiproliferative activity
RU2340618C2 (en) * 2002-11-18 2008-12-10 Ф.Хоффманн-Ля Рош Аг Diazinopyrimidines and pharmaceutical composition containing them
US7098332B2 (en) 2002-12-20 2006-08-29 Hoffmann-La Roche Inc. 5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
RU2350617C2 (en) 2003-04-10 2009-03-27 Ф.Хоффманн-Ля Рош Аг Pyrimidine compounds with selective inhibition of "¦-¦" and "l¦l¦" activity
ATE451115T1 (en) * 2003-07-07 2009-12-15 Van Andel Res Inst INHIBITION OF TUMOR ANGIOGENESIS BY A COMBINATION OF THROMBOSPONDIN-1 AND VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS
KR100816321B1 (en) * 2003-11-13 2008-03-24 에프. 호프만-라 로슈 아게 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
WO2005105097A2 (en) * 2004-04-28 2005-11-10 Gpc Biotech Ag Pyridopyrimidines for treating inflammatory and other diseases
US20070054916A1 (en) * 2004-10-01 2007-03-08 Amgen Inc. Aryl nitrogen-containing bicyclic compounds and methods of use
US20090131430A1 (en) * 2004-11-23 2009-05-21 Palle Venkata P Pyrido'2,3-dipyrimidines as anti-inflammatory agents
EP1846403A1 (en) * 2005-02-02 2007-10-24 Ranbaxy Laboratories Limited Azabicyclo derivatives as anti-inflammatory agents
WO2007036791A1 (en) * 2005-09-28 2007-04-05 Ranbaxy Laboratories Limited Pyrido-pyridimidine derivatives useful as antiinflammatory agents
KR20080083046A (en) 2006-01-31 2008-09-12 에프. 호프만-라 로슈 아게 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
KR100661523B1 (en) * 2006-06-09 2006-12-26 주식회사 청용산기 Box correcting device of stitching progress for carton box erecting
EP1914234A1 (en) 2006-10-16 2008-04-23 GPC Biotech Inc. Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors
CA2668731A1 (en) 2006-11-09 2008-05-15 Tobias Gabriel Kinase inhibitors and methods for using the same
WO2008078249A1 (en) * 2006-12-21 2008-07-03 Ranbaxy Laboratories Limited Anti-inflammatory agents
EP2112150B1 (en) 2008-04-22 2013-10-16 Forma Therapeutics, Inc. Improved raf inhibitors
KR101106162B1 (en) * 2010-04-20 2012-01-20 주식회사 청용산기 Stitching device for packing box making apparatus
ES2694223T3 (en) * 2012-03-22 2018-12-19 Oscotec, Inc. Pyridopyrimidine compounds and their use as FLT3 inhibitors
US9321786B2 (en) 2013-03-15 2016-04-26 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
KR102350704B1 (en) 2013-03-15 2022-01-13 셀젠 카르 엘엘씨 Heteroaryl compounds and uses thereof
EA036160B1 (en) 2013-03-15 2020-10-08 Селджен Кар Ллс Heteroaryl compounds and uses thereof
CN107074847A (en) 2014-09-12 2017-08-18 生物实验萨纽斯药物有限公司 New Pyridopyrimidine derivatives compound
CA3128468A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2020142612A1 (en) * 2019-01-03 2020-07-09 Genentech, Inc. Pyrido-pyrimidinone and pteridinone compounds as inhibitors of endoribonuclease inositol requiring enzyme i (ire i alpha) for the treatment of cancer diseases.
PE20220387A1 (en) * 2019-05-31 2022-03-18 Servier Lab HETEROBICYCLIC MAT2A INHIBITORS AND METHODS OF USE FOR THE TREATMENT OF CANCER
WO2022052924A1 (en) * 2020-09-11 2022-03-17 上海凌达生物医药有限公司 Preparation method for class of nitrogen-containing fused ring compounds and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT790997E (en) * 1994-11-14 2000-06-30 Warner Lambert Co 6-ARYL PYRIDINE-2,3-D | PYRIMIDINES AND NAFTIRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
IL117923A (en) * 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
AU763839B2 (en) * 1998-05-26 2003-07-31 Warner-Lambert Company Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation

Also Published As

Publication number Publication date
AU2001293784B2 (en) 2007-08-30
CN1275964C (en) 2006-09-20
GT200100191A (en) 2002-05-16
JP2004507541A (en) 2004-03-11
JP4141830B2 (en) 2008-08-27
CA2420286A1 (en) 2002-03-07
WO2002018380A1 (en) 2002-03-07
KR100571339B1 (en) 2006-04-17
UY26918A1 (en) 2002-02-28
EP1315726A1 (en) 2003-06-04
AR033681A1 (en) 2004-01-07
MXPA03001821A (en) 2003-06-04
BR0113628A (en) 2003-07-01
PE20020406A1 (en) 2002-05-17
ZA200301079B (en) 2004-05-07
CN1451005A (en) 2003-10-22
KR20030022422A (en) 2003-03-15
AU9378401A (en) 2002-03-13

Similar Documents

Publication Publication Date Title
PA8527301A1 (en) 7-OXO-PYRIDOPIRIMIDINAS
BRPI0417006A (en) local intraosseous administration of bone forming agents and anti-resorptive agents and devices therefor
UY26813A1 (en) COMPOUNDS TO TREAT ALZHEIMER'S DISEASE
DK1346041T3 (en) Therapeutic agents and methods for their use in the treatment of an amyloidogenic disease
CY1111246T1 (en) PREVENTION AND TREATMENT OF INFLAMMATORY AND / OR IMMUNIATED BONE LOSS
BR0307998A (en) Substituted hydroxyethylamines
PA8596901A1 (en) P38 INHIBITORS AND METHODS OF USE OF THEM
NO20035474D0 (en) Prodrugs of GABA analogs, compositions and their use
GB0223040D0 (en) Therapeutic compounds
BR0011448A (en) Amide Substituted Imidazoquinolines
BRPI0212733B8 (en) pharmaceutical composition comprising serotonin reuptake inhibitor compound, and use thereof
UY28376A1 (en) THERAPEUTIC AGENTS
BRPI0607017B8 (en) pharmaceutical composition comprising memantine and donezepil, and their use for the treatment of snc-related conditions
CO5570667A2 (en) SUBSTITUTED SUBSTITUTE SUBSTITUTED SUBSTITUTE COMPOUNDS WITH HETEROARILO FOR THE TREATMENT OF DISEASES
BR0116034A (en) Substituted imidazopyridines
CY1107956T1 (en) USE OF 2-AMINOTETRALINE SUBSTITUTES FOR PREVENTIVE TREATMENT OF PARKINS DISEASE
GB0108592D0 (en) Therapeutic agents
CY1109732T1 (en) USE OF PRODUCERS OF VENZO-CONNECTED SULFAMIDI EQUIPMENT FOR TREATMENT PAIN
SE0301446D0 (en) New Compounds
CY1110537T1 (en) UNIONS AND METHODS FOR THE DISEASE EDUCATION
UY29790A1 (en) DIARILOIMIDAZOLA-4-CARBOXAMID SALTS, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCESSES AND APPLICATIONS
BR0316723A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
HN2002000110A (en) USE OF (Z) - 2 - CIANO - 3 - HYDROXY - BUTIL - 2 - ENOIC ACID (4 '- TRIFLUOROMETIL PHENYL) - AMIDA FOR THE TREATMENT OF MULTIPLE SCLEROSIS.
UY28377A1 (en) THERAPEUTIC AGENTS
BR0211830A (en) Azithromycin single dose